1. Home
  2. BIOX vs LSTA Comparison

BIOX vs LSTA Comparison

Compare BIOX & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$0.66

Market Cap

35.6M

Sector

Industrials

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.84

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
LSTA
Founded
2001
1980
Country
Argentina
United States
Employees
N/A
21
Industry
Agricultural Chemicals
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
29.2M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
BIOX
LSTA
Price
$0.66
$2.84
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$4.33
$15.00
AVG Volume (30 Days)
382.1K
77.0K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
N/A
$35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$0.35
$1.81
52 Week High
$5.18
$5.07

Technical Indicators

Market Signals
Indicator
BIOX
LSTA
Relative Strength Index (RSI) 62.31 8.70
Support Level $0.53 $2.29
Resistance Level $0.67 $3.03
Average True Range (ATR) 0.07 0.22
MACD 0.02 -0.26
Stochastic Oscillator 97.60 2.19

Price Performance

Historical Comparison
BIOX
LSTA

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: